Diagnostic accuracy of first-trimester free β HCG and pregnancy-associated plasma protein-A assays (original) (raw)

The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay system

Kevin Spencer

Annals of Clinical Biochemistry, 2003

View PDFchevron_right

First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free β-hCG and pregnancy-associated plasma protein-A assays

Kevin Spencer

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2005

View PDFchevron_right

Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy

James Densem

BJOG: An International Journal of Obstetrics and Gynaecology, 1996

View PDFchevron_right

Maternal serum screening for Down's syndrome in the first trimester of pregnancy

Ettore Cariati

BJOG: An International Journal of Obstetrics and Gynaecology, 1995

View PDFchevron_right

The use of free beta-hCG in antenatal screening for Down's syndrome

James Densem

BJOG: An International Journal of Obstetrics and Gynaecology, 1993

View PDFchevron_right

Evaluation of First Trimester Contingent Test for Down ’ S Syndrome Screening

Kusagradhi Ghosh

Journal of Evolution of medical and Dental Sciences, 2015

View PDFchevron_right

Comparison of first-trimester contingent screening strategies for Down syndrome

Daljit Sahota

Ultrasound in Obstetrics & Gynecology, 2010

View PDFchevron_right

Importance of the integrated test in the Down’s syndrome screening algorithm

Drahomira Springer

Journal of Medical Screening, 2018

View PDFchevron_right

The utility of fetal biometry as an adjunct to the multiple-marker screening test for Down syndrome

John Owen

American Journal of Obstetrics and Gynecology, 1994

View PDFchevron_right

Four-marker serum screening for Down's syndrome

James Densem

Prenatal Diagnosis, 1994

View PDFchevron_right

Ductus venosus pulsatility index measurement reduces the false-positive rate in first-trimester screening

Joris van der Post

Ultrasound in Obstetrics & Gynecology, 2010

View PDFchevron_right

Incorporation of inhibin-A in second-trimester screening for Down syndrome

Peter Benn

Obstetrics & Gynecology, 2003

View PDFchevron_right

Second Trimester Antenatal Screening for Down’s Syndrome

Guido Vranken

View PDFchevron_right

Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women

Karin Sundberg

Ultrasound in Obstetrics and Gynecology, 2005

View PDFchevron_right

Repeat maternal serum testing in multiple marker down's syndrome screening programmes

James Densem

Prenatal Diagnosis, 1994

View PDFchevron_right

Maternal serum markers in screening for Down syndrome

Ann Tabor

Clinical Genetics, 2008

View PDFchevron_right

Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies

Adrian Shulman

Prenatal Diagnosis, 2004

View PDFchevron_right

Maternal serum screening for Down's syndrome in early pregnancy

James Densem

BMJ, 1988

View PDFchevron_right

Value of the Combined Test in Prenatal Diagnostics

Dragan Loncar

Balkan Journal of Medical Genetics, 2010

View PDFchevron_right

The comprehensive midtrimester test: High-sensitivity down syndrome test

Ray Bahado-Singh

American Journal of Obstetrics and Gynecology, 2002

View PDFchevron_right

HealthIssue Prenatal Serum and Ultrasound Screening for Downûs Syndrome P

Saifon Chawanpaiboon

View PDFchevron_right

Credibility of the combined test in prenatal diagnostics

dragan loncar

Genetika, 2011

View PDFchevron_right

First trimester screening for Down syndrome using free β hCG, total hCG and PAPP-A: an exploratory study

Kevin Spencer

Prenatal Diagnosis, 2007

View PDFchevron_right

Advances in prenatal screening for Down syndrome: I. General principles and second trimester testing

Peter Benn

Clinica Chimica Acta, 2002

View PDFchevron_right

Maternal serum screening for Down's syndrome on population basis

Ulf-Håkan Stenman

Acta Obstetricia et Gynecologica Scandinavica, 1997

View PDFchevron_right

Value of maternal serum unconjugated oestriol measurement in prenatal screening for Down's syndrome

Hilary Watt

Prenatal Diagnosis, 1994

View PDFchevron_right

Combining first and second trimester markers for Down syndrome screening: Think twice

Kate Brameld

Australian and New Zealand Journal of Obstetrics and Gynaecology, 2008

View PDFchevron_right

Use of the disutility ratio in prenatal screening for Down's syndrome

Eva Pajkrt

BJOG: An International Journal of Obstetrics and Gynaecology, 1999

View PDFchevron_right

Reproducibility of risk figures in 2nd-trimester maternal serum screening for Down syndrome: comparison of 2 laboratories

Peter Benn

Clinical chemistry, 2006

View PDFchevron_right

Combined Second-Trimester Biochemical and Ultrasound Screening for Down Syndrome

Peter Benn

Obstetrics & Gynecology, 2002

View PDFchevron_right

Trade-offs in prenatal detection of Down syndrome.

Pedro Gallo

… journal of public …, 1998

View PDFchevron_right

Are second-trimester minor sonographic markers for Down syndrome useful in patients who have undergone first-trimester combined screening?

Hima Tam

American Journal of Obstetrics and Gynecology, 2010

View PDFchevron_right

Down’s Syndrome Screening in the First Trimester with Additional Serum Markers: Indian Parameters

sujatha jagadeesh

The Journal of Obstetrics and Gynecology of India

View PDFchevron_right

Cross-trimester repeated measures testing for Down's syndrome screening: an assessment

Mary D'Alton

Health technology assessment (Winchester, England), 2010

View PDFchevron_right

Strategies for antenatal detection of Down's syndrome

Jonathan Wyllie

Archives of Disease in Childhood - Fetal and Neonatal Edition, 1997

View PDFchevron_right